Controlled Substances and Drug Diversion: Introduction 101

SKS Medication Safety Series, Chapter 12 of 15 · Standard SİY11

Prof. Dr. Mehmet Nurullah Kurutkan, Düzce Üniversitesi İşletme Fakültesi Sağlık Yönetimi Bölümü

← Series hub: all 15 chapters

Chapter at a glance

Narcotic and psychotropic medicines are essential for pain and sedation, but they carry risks of overdose, abuse and theft. This chapter covers safe handling of controlled substances in hospital: locked storage, custody and handover records, documentation discrepancies and diversion. It corresponds to SKS SİY11 (Sağlık Bakanlığı, 2020).

Evidence base: 115 records of a 4948-record Web of Science corpus on hospital medication safety (Section 7). Reading time: about 25 minutes. Prior knowledge required: none.

Learning objectives

After working through this chapter, the reader should be able to:

  1. state the SKS SİY11 requirements for narcotics and psychotropics;
  2. explain drug diversion and its contributors;
  3. describe documentation and handover risks;
  4. summarise interventions that reduce narcotic-related adverse events.

Key concepts

Contents: How this chapter was produced · 1. Introduction · 2. History and development · 3. Definitions and conceptual schema · 4. Distinguishing it from neighbouring concepts · 5. Types and classifications · 6. Theoretical frameworks and models · 7. Themes and bibliometric profile · 8. The situation in Türkiye · 9. Debates and contradictions in the literature · 10. Measurement problems · 11. Research gaps and agenda · 12. Implications for practice today · Summary · Discussion questions · Further reading · Glossary · References · Source verification and AI use statement · Data and supplementary material

How this chapter was produced

Box 1. Method

Database: Web of Science Core Collection (SCI-EXPANDED, SSCI, ESCI); English; articles and reviews (including early access). Search date: 16 November 2026; all years (1981 to 2027).

Search: (#1 medication safety and error terms AND #2 hospital settings AND #3 fifteen SKS content blocks) NOT #4 animal and preclinical terms; the full string is on the series hub.

Screening: five export files (4955 records) were merged; 7 duplicates were removed by WoS accession number, DOI and normalised title plus year, leaving 4948 records. Records were assigned to this sub-topic when its term set (controlled substance or drug, narcotic, diversion) appeared in the title or keywords or, for this thin sub-topic, the abstract; a record can belong to several sub-topics. Included here: 115 records (31 with the term in the title; 13 reviews).

Limitations: single database; English only; assignment by term matching, checked by reading titles of the most cited and most recent records; claims are checked against abstracts, not full texts.

Web of Science Core Collection, 5 export files
4955 records
↓ duplicates removed: 7
4948 unique records (hospital medication safety corpus)
↓ sub-topic term set applied to title/keywords/abstract
Included in this chapter: 115
31 title matches; 13 reviews
Not in this chapter: 4833
other chapters or general records
Figure 1. Flow of records for this chapter. Source: produced by the author from the Web of Science corpus.

1. Introduction

SKS requires that narcotic and psychotropic drugs be kept in locked areas, with defined exceptions and extra precautions; that handover be recorded with the patient, frequency and dose, date, who administered, to whom and how much was handed over, and signatures of both parties; that reports be written for narcotics damaged during storage or transport; and that narcotics destroyed because of expiry, spoilage or risk be recorded (Sağlık Bakanlığı, 2020).

The literature adds two concerns. Narcotic-related events are the most common adverse drug events in hospitalised children (Sharek et al., 2008), and drug losses and theft from the health care system are accelerating, putting pressure on hospitals to prevent diversion (Fan et al., 2019).

2. History and development

In 1992 a study asked whether narcotic use in hospital was reasonably safe (Whipple et al., 1992), and in 1994 the same group described a computerised method for identifying overdoses with patient-controlled analgesia (Whipple et al., 1994). Paediatric quality collaboratives targeted narcotic-related adverse events in 2008 (Sharek et al., 2008). The 2010s brought feedback interventions for prescribing errors (Sullivan et al., 2013) and quality improvement for documentation (Dolan et al., 2019). A 2019 scoping review organised the diversion literature (Fan et al., 2019), and a 2022 failure mode analysis described diversion vulnerabilities in hospital pharmacies (De Vries et al., 2022).

  • 1992 Narcotic use in hospital assessed for safety (Whipple et al., 1992).
  • 1994 Computerised identification of PCA overdoses in hospitalised patients (Whipple et al., 1994).
  • 2008 14-hospital collaborative reduces narcotic-related ADEs in children (Sharek et al., 2008).
  • 2013 Personalised feedback reduces narcotic prescribing errors in a NICU (Sullivan et al., 2013).
  • 2019 Scoping review of diversion contributors and safeguards (Fan et al., 2019).
  • 2022 FMEA of diversion vulnerabilities in inpatient pharmacies (De Vries et al., 2022).
  • 2023 Narcotic drug management processes in a Turkish university hospital (Taser et al., 2023).
Figure 2. Timeline of milestones in the corpus. Source: produced by the author from the Web of Science corpus.

3. Definitions and conceptual schema

Table 1. How the corpus defines the concept
SourceYearDisciplineDefinition (paraphrased)Emphasised dimension
Sağlık Bakanlığı, 20202020Accreditation standardLocked storage, recorded handover with signatures, reports for damaged items and recorded destruction.Custody and records
Fan et al., 20192019Hospital medicineDiversion as loss or theft of controlled drugs from the hospital, with system-level contributors and safeguards.Diversion
De Vries et al., 20222022Patient safetyVulnerabilities for diversion within handling, data entry and verification tasks of the medication-use process.Process vulnerability
Dolan et al., 20192019Clinical informaticsDocumentation discrepancies as legally relevant mismatches in controlled substance records.Documentation
Sharek et al., 20082008PaediatricsNarcotic-related adverse drug events as the most common ADEs in hospitalised children.Clinical harm
Common core
controlled medicines are kept, handed over, used and destroyed under complete, verifiable records that protect both patients and staff
Clinical harm (overdose)Custody and handoverDocumentationDiversionWaste and destruction
Figure 3. Conceptual schema: the shared core of the definitions and the dimensions on which they diverge. Source: produced by the author from the Web of Science corpus.

The definitions combine two different risks: clinical harm to patients (Sharek et al., 2008) and loss to illegitimate use (Fan et al., 2019). SKS addresses both through custody records (Sağlık Bakanlığı, 2020).

4. Distinguishing it from neighbouring concepts

Controlled drugs overlap most with high-alert medicines, prescribing and administration (Figure 4): opioids are both high-alert and controlled, and most harm arises at ordering and bedside use. Smaller overlaps with storage and waste reflect cabinet storage and documented disposal.

High-alert/LASA (SİY10)17%
Prescribing (SİY05)14%
Administration (SİY08)12%
Reporting/indicators (SİY14)9%
Preparation/dispensing (SİY06)7%
Pharmacovigilance (SİY09)5%
Returns/waste (SİY13, SİY15)5%
Formulary (SİY02)4%
Storage (SİY04)4%
Own meds/reconciliation (SİY12)4%
Rational use/AMS (SİY01.02)3%
Transport/distribution (SİY07)3%
Interactions/compatibility (SİY03)3%
Governance (SİY01)0%
Figure 4. Neighbouring-concept matrix: percentage of the 115 records of this chapter that are also tagged with each other SKS sub-topic. Source: produced by the author from the Web of Science corpus.
Table 2. Distinguishing criteria
Neighbouring conceptHow it differs
High-alert medications (SİY10)Opioids are both; high-alert status concerns harm in error (Sağlık Bakanlığı, 2020).
Storage (SİY04)Locked storage is a storage rule with legal force (Zheng et al., 2021).
Returns and waste (SİY13, SİY15)Controlled drug waste must be documented and carries costs and diversion risk (Hertig et al., 2021).

5. Types and classifications

Diversion contributors are grouped by step: procurement, storage, prescribing, dispensing, administration and waste (Fan et al., 2019). Documentation errors arise especially at intraoperative handoffs between anaesthesia providers (Epstein et al., 2017).

6. Theoretical frameworks and models

Healthcare failure mode and effect analysis structures diversion risk assessment (De Vries et al., 2022); Lean Six Sigma (Creed et al., 2019) and theory of change with visual analytics (Dolan et al., 2019) structure improvement projects.

7. Themes and bibliometric profile

The literature is small (Figure 5). A visual analytics dashboard combined with quality improvement reduced documentation discrepancies in the operating room (Dolan et al., 2019); Lean Six Sigma redesign cut nurse journeys to pharmacy for controlled drug collection by 44% (Creed et al., 2019). Narcotic prescriptions written by trainees at discharge were error-prone, nearly 3% with potential for significant harm (Lee et al., 2009).

Records per year 2026 (incomplete)

061219901995200020052010201520202025

Most frequent journals

Annals of Pharmacotherapy5
Joint Commission Journal on Quality and Patient Safety4
American Journal of Health-System Pharmacy4
Frontiers in Pharmacology3
Pediatrics3
Hospital Pharmacy2

Most frequent countries

USA60
Australia14
Canada9
Peoples R China7
England5

Most frequent author keywords: patient safety (12), medication errors (8), medication management (6), psychotropic drugs (4), quality improvement (4), pediatrics (4), medication safety (4), diversion (4), pharmacy (4), adverse drug events (4). Six records have no address information.

Figure 5. Bibliometric profile of the 115 records (1992 to 2026). Records dated before 1990 are counted at 1990 and 2027 early-access records at 2026. Source: produced by the author from the Web of Science corpus.

8. The situation in Türkiye

One record has Turkish authors: a description of narcotic drug management processes in a university hospital, emphasising patient and employee safety and prevention of uncontrolled circulation (Taser et al., 2023).

9. Debates and contradictions in the literature

Individual or system accountability? The scoping review argues that system-based strategies broaden the response to diversion beyond individual accountability (Fan et al., 2019).

Does technology close the gaps? Cabinets, bar codes and closed-loop systems help, but processes must supplement their capabilities (Zheng et al., 2021).

Safety or efficiency? Legal procedures consume nursing time; redesign can preserve control while releasing time (Creed et al., 2019).

10. Measurement problems

Diversion is hidden by nature; studies rely on discrepancy counts and audits (Dolan et al., 2019). Narcotic-related harm was tracked with standardised measures across sites in a collaborative (Sharek et al., 2008). Few studies quantify diversion incidence.

11. Research gaps and agenda

  1. How often does diversion occur in Turkish hospitals, and how is it detected? (Taser et al., 2023)
  2. Which safeguards prevent diversion at the waste step? (Fan et al., 2019)
  3. How can handoffs reduce controlled drug documentation errors? (Epstein et al., 2017)
  4. Can analytics detect diversion patterns early? (Dolan et al., 2019)
  5. How should SKS handover records be digitised?

12. Implications for practice today

Combine SKS custody rules with analytics: monitor discrepancies on a dashboard (Dolan et al., 2019), assess vulnerabilities with FMEA (De Vries et al., 2022), standardise intraoperative handoffs (Epstein et al., 2017) and use feedback for prescribers (Sullivan et al., 2013).

Summary

  • Controlled drugs carry risks of clinical harm and diversion.
  • SKS SİY11 requires locked storage and signed handover records.
  • Diversion is a system problem with safeguards at every step.
  • Documentation discrepancies respond to quality improvement.
  • Turkish evidence is limited to a process description.

Discussion questions

  1. Why are handover signatures important for both patients and staff?
  2. List diversion vulnerabilities at each step of the medication-use process.
  3. How could a dashboard reveal diversion?
  4. Design a waste witnessing procedure for an operating theatre.
  5. How would you balance legal control and nursing workload?

Further reading

Glossary

TurkishEnglishShort definition
Kontrole tabi ilaçControlled substanceDrug under legal control
İlaç saptırmaDrug diversionTransfer to illegitimate use
Devir teslimHandover (chain of custody)Documented transfer between staff
Kayıt uyumsuzluğuDocumentation discrepancyMismatch in controlled drug records

References

Creed, M., McGuirk, M., Buckley, R., De Brún, A., & Kilduff, M. (2019). Using Lean Six Sigma to Improve Controlled Drug Processes and Release Nursing Time. Journal of Nursing Care Quality, 34(3), 236-241. https://doi.org/10.1097/NCQ.0000000000000364

De Vries, M., Fan, M., Tscheng, D., Hamilton, M., & Trbovich, P. (2022). Vulnerabilities for Drug Diversion in the Handling, Data Entry, and Verification Tasks of 2 Inpatient Hospital Pharmacies: Clinical Observations and Healthcare Failure Mode and Effect Analysis. Journal of Patient Safety, 18(1), E227-E235. https://doi.org/10.1097/PTS.0000000000000744

Dolan, J. E., Lonsdale, H., Ahumada, L. M., Patel, A., Samuel, J., Jalali, A., Peck, J., Derosa, J. C., Rehman, M., Varughese, A. M., & Fernandez, A. M. (2019). Quality Initiative Using Theory of Change and Visual Analytics to Improve Controlled Substance Documentation Discrepancies in the Operating Room. Applied Clinical Informatics, 10(3), 543-551. https://doi.org/10.1055/s-0039-1693688

Epstein, R. H., Dexter, F., Gratch, D. M., & Lubarsky, D. A. (2017). Intraoperative Handoffs Among Anesthesia Providers Increase the Incidence of Documentation Errors for Controlled Drugs. Joint Commission Journal on Quality and Patient Safety, 43(8), 396-402. https://doi.org/10.1016/j.jcjq.2017.02.010

Fan, M., Tscheng, D., Hamilton, M., Hyland, B., Reding, R., & Trbovich, P. (2019). Diversion of Controlled Drugs in Hospitals: A Scoping Review of Contributors and Safeguards. Journal of Hospital Medicine, 14(7), 419-428. https://doi.org/10.12788/jhm.3228

Hertig, J., Jarrell, K., Arora, P., Nwabueze, J., Moureaud, C., Degnan, D. D., & Trujillo, T. (2021). A Continuous Observation Workflow Time Study to Assess Intravenous Push Waste. Hospital Pharmacy, 56(5), 584-591. https://doi.org/10.1177/0018578720931754

Lee, B. H., Lehmann, C. U., Jackson, E. V., Kost-Byerly, S., Rothman, S., Kozlowski, L., Miller, M. R., Pronovost, P. J., & Yaster, M. (2009). Assessing Controlled Substance Prescribing Errors in a Pediatric Teaching Hospital: An Analysis of the Safety of Analgesic Prescription Practice in the Transition From the Hospital to Home. Journal of Pain, 10(2), 160-166. https://doi.org/10.1016/j.jpain.2008.08.004

Sağlık Bakanlığı. (2020). Sağlıkta kalite standartları: Hastane (Sürüm 6.1). Sağlık Hizmetleri Genel Müdürlüğü, Sağlıkta Kalite, Akreditasyon ve Çalışan Hakları Dairesi Başkanlığı. https://dosyamerkez.saglik.gov.tr/Eklenti/41258/0/skshastane-seti-s-61–09082021pdf.pdf

Sharek, P. J., McClead, R. E., Taketomo, C., Luria, J. W., Takata, G. S., Walti, B., Tanski, M., Nelson, C., Logsdon, T. R., Thurm, C., & Federico, F. (2008). An intervention to decrease narcotic-related adverse drug events in children's hospitals. Pediatrics, 122(4), E861-E866. https://doi.org/10.1542/peds.2008-1011

Sullivan, K. M., Suh, S., Monk, H., & Chuo, J. (2013). Personalised performance feedback reduces narcotic prescription errors in a NICU. BMJ Quality & Safety, 22(3), 256-262. https://doi.org/10.1136/bmjqs-2012-001089

Taser, M., Yüksel, S., Çelik, M., & Sarica, C. (2023). Narcotic Drug Management Processes Practice: University Hospital Example. Addicta: The Turkish Journal on Addictions, 10(1), 37-44. https://doi.org/10.5152/ADDICTA.2023.22073

Whipple, J. K., Ausman, R. K., & Quebbeman, E. J. (1992). Narcotic use in the hospital – reasonably safe. Annals of Pharmacotherapy, 26(7-8), 897-901. https://doi.org/10.1177/106002809202600705

Whipple, J. K., Quebbeman, E. J., Lewis, K. S., Gaughan, L. M., Gallup, E. L., & Ausman, R. K. (1994). Identification of patient-controlled analgesia overdoses in hospitalized-patients – a computerized method of monitoring adverse events. Annals of Pharmacotherapy, 28(5), 655-658. https://doi.org/10.1177/106002809402800517

Zheng, W. Y., Lichtner, V., Van Dort, B. A., & Baysari, M. T. (2021). The impact of introducing automated dispensing cabinets, barcode medication administration, and closed-loop electronic medication management systems on work processes and safety of controlled medications in hospitals: A systematic review. Research in Social & Administrative Pharmacy, 17(5), 832-841. https://doi.org/10.1016/j.sapharm.2020.08.001

Source verification and AI use statement

Source verification. All 14 references were generated programmatically from the Web of Science records of the corpus, so authors, year, title, journal and DOI match the records exactly; every in-text citation was cross-checked by code against the reference list. Claims were checked against the record abstracts; full texts were not read. The SKS Hospital Set (Version 6.1) is the only source outside the corpus; it was accessed and read for this chapter.

AI use statement. Claude (Anthropic) was used to merge and de-duplicate the Web of Science exports, assign records to sub-topics, compute the bibliometric indicators and figures, and draft the text under the author’s instructions. The author is responsible for the final content.

Data and supplementary material

Supplementary file S1 (Excel) lists the 115 records of this chapter (authors, year, title, journal, DOI, title match flag), together with the full screening log of the 4948-record corpus and the citation verification report. The list is not reproduced here; it is available from the author on request.

← Chapter 11: High-Alert and Look-Alike Sound-Alike MedicationsChapter 13: Patients’ Own Medicines and Medication Reconciliation →